Mamintas, Baby Boy .
HRN: 25-50-01 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/20/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/20/2024
07/27/2024
IV
330mg
Q 8 Hours
T/C Neonatal Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes